Acalabrutinib in mantle cell lymphoma

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalThe Lancet
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Mantle-Cell Lymphoma
acalabrutinib

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Acalabrutinib in mantle cell lymphoma. / Kapoor, Prashant; Ansell, Stephen Maxted.

In: The Lancet, 01.01.2017.

Research output: Contribution to journalArticle

@article{7b63c3444a7d4422a42d8e55c4178737,
title = "Acalabrutinib in mantle cell lymphoma",
author = "Prashant Kapoor and Ansell, {Stephen Maxted}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/S0140-6736(17)33256-7",
language = "English (US)",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Acalabrutinib in mantle cell lymphoma

AU - Kapoor, Prashant

AU - Ansell, Stephen Maxted

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85037723617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037723617&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(17)33256-7

DO - 10.1016/S0140-6736(17)33256-7

M3 - Article

C2 - 29241978

AN - SCOPUS:85037723617

JO - The Lancet

JF - The Lancet

SN - 0140-6736

ER -